본문 바로가기
주메뉴 바로가기
HLBELL
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Hair Cell Therapeutic
Intellectual Property Rights
Pipeline
Development Stage
Product
Hutrigel®-RU
Primary Human Hepatocytes
Primary Animal Hepatocytes
Medical Plastic
PR
Notice
News
Sitemap
Contact
ENG
KOR
ENG
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Hair Cell Therapeutic
Intellectual Property Rights
Pipeline
Development Stage
Product
Hutrigel®-RU
Primary Human Hepatocytes
Primary Animal Hepatocytes
Medical Plastic
PR
Notice
News
SITEMAP
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Hair Cell Therapeutic
Intellectual Property Rights
Pipeline
Development Stage
Product
Hutrigel®-RU
Primary Human Hepatocytes
Primary Animal Hepatocytes
Medical Plastic
PR
Notice
News
PR
Biotech Company Specialized in Regenerative Medicine
News
Notice
News
News
라이프리버,간줄기세포치료제 ‘헤파스템’ 2b상임상계획승인
Date 2020.09.04
Hit 1443
기사원문 :
http://www.yakup.com/news/index.html?mode=view&cat=12&nid=217817
PREV
라이프리버, 바이오인공간 임상2b상 식약처 승인
NEXT
라이프리버, 간세포 동결보존기술 산업핵심기술개발사업 선정
LIST